Clinical trial Recruiting at 1 site Interventional Ages 18 to 29

Solution-Focused Therapy for Generalized Anxiety Disorder in emerging adults

Official title: Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults

Run by International Islamic University, Islamabad · NCT07798063 · Data updated 2026-11-12

This study tests whether Solution-Focused Therapy can reduce worry and anxiety in 18-29 year-olds with mild to moderate GAD in Pakistan.

Quick facts

Study typeInterventional
Ages18 Years to 29 Years
SexAll
Enrollment50 (estimated)
SponsorInternational Islamic University, Islamabad
Academic / other
Locations1 site (Islamabad)
StatusRecruiting
StartedJanuary 5, 2026
Main results expectedDecember 15, 2026
Study endsDecember 28, 2026
Registry record updatedSeptember 1, 2026
Trial IDNCT07798063 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 18-29 years old with mild to moderate GAD, not currently in psychotherapy for anxiety, and able to participate in the therapy sessions.

Probably not a fit

Individuals with severe GAD, psychotic disorders, or those already receiving anxiety-focused psychotherapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial examines the effect of Solution-Focused Therapy (SFT) compared with a waitlist control on anxiety symptoms in emerging adults with Generalized Anxiety Disorder in Pakistan. Participants aged 18-29 with mild to moderate GAD will be screened using the GAD-7 and randomized to receive SFT or be placed on a waitlist. Changes in anxiety symptoms will be measured before and after the intervention to determine SFT’s effectiveness. The study addresses a gap in culturally validated, time-efficient psychological options for anxiety among university-age individuals in Pakistan. The approach leverages a shorter, goal-oriented therapy model that may offer a practical alternative to longer therapies.

Why it matters

Potential benefit: If successful, participants who receive SFT may experience reduced anxiety symptoms and improved daily functioning.

How similar studies have gone: Previous research suggests short, structured therapies can help anxiety, but evidence for SFT in Pakistani emerging adults is limited and this study explores novel cultural applicability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Participants with mild to moderate scores of generalized anxiety disorder upon baseline assessment will be included in the study.

Exclusion Criteria: Individuals will be excluded if they reported a diagnosis of psychotic disorder, and those receiving psychotherapy or counseling for anxiety.

Where it's running

  • International Islamic University Islamabad (IIUI)
    Islamabad, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.